Search for: "Pfizer Pharmaceutic, Inc."
Results 1 - 20
of 667
Sort by Relevance
|
Sort by Date
1 May 2024, 1:18 pm
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
29 Apr 2024, 4:15 am
However, GSK contends their competitors, Pfizer Inc. and Pharmacia & Upjohn Co. [read post]
29 Apr 2024, 4:15 am
However, GSK contends their competitors, Pfizer Inc. and Pharmacia & Upjohn Co. [read post]
18 Mar 2024, 6:27 am
Pfizer, Inc., issued on March 6. [read post]
13 Mar 2024, 7:24 pm
Patent No. 7,553,941 to Pfizer Inc. for purposes of obtaining marketing authorization for NGENLA (Somatrogonghla). [read post]
11 Jan 2024, 12:03 am
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
28 Dec 2023, 12:56 pm
Examples Of False Claims Act Cases Involving Copay Waivers In 2018, Pharmaceutical company Actelion Pharmaceuticals US, Inc agreed to pay $360 million to resolve claims that it illegally used a foundation as a conduit to pay the co-pays of thousands of Medicare patients taking Actelion’s pulmonary arterial hypertension drugs, in violation of the False Claims Act. [read post]
20 Dec 2023, 5:00 am
Monoclonal Antibodies Inc., 1985) protected large genus claims. [read post]
10 Jul 2023, 6:47 am
The SEC also brought charges against five individuals, including a Massachusetts police chief, in connection with their trading before the announcement of an offer by Alexion Pharmaceuticals Inc. to acquire Portola Pharmaceuticals Inc. [read post]
6 Jul 2023, 6:11 am
., Inc., 132 S. [read post]
9 Jun 2023, 8:36 am
In Part One, I reviewed the basic structure and function of the pharmaceutical industry, as well as the theory of harm that the FTC is bringing. [read post]
9 Jun 2023, 8:36 am
In Part One, I reviewed the basic structure and function of the pharmaceutical industry, as well as the theory of harm that the FTC is bringing. [read post]
5 Apr 2023, 5:18 am
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
14 Feb 2023, 12:29 pm
</span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <p> <span style="display: initial;"> <span style="display: initial;"> Some well-known patent infringement </span> </span> <a href="https://www.greyb.com/largest-patent-infringement-awards/" target="_blank"… [read post]
1 Feb 2023, 9:05 pm
Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6 acquisition of Biohaven Pharmaceuticals, $5.4 billion acquisition of Global Blood Therapeutics and $525 million acquisition of ReViral. [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
14 Nov 2022, 12:15 am
Food & Drug Administration, financial results, and an impending merger with a division of Pfizer Inc. [read post]
4 Aug 2022, 7:54 pm
Pfizer, Inc. v. [read post]
25 Jul 2022, 1:52 pm
” Pfizer, Inc. v. [read post]
25 May 2022, 2:26 am
The Appellants are both pharmaceutical companies fined by the CMA and both appealed to the Competition Appeal Tribunal (CAT) challenging the CMA’s decision. [read post]
